WASHINGTON, Dec. 22 (TNSFR) -- The International Trade Commission (ITC) voted to begin an investigation into allegations of trade secret theft involving cancer treatments. The decision follows a complaint filed by AbbVie Inc., North Chicago, Illinois, ImmunoGen Inc., Waltham, Massachusetts, and ImmunoGen Switzerland, Zug, which claims that several companies imported products using misappropriated technology.

The dispute centers on antibody drug conjugates, specifically a product kno . . .

Click here for more information about our products